Lung Cancer Applications
-
Ceritinib
This active molecular is a selective inhibitor of ALK(anaplastic lymphoma kinase)which is a target found in NSCLC (metastatic non-small cell lung cancer).https://www.bocsci.com/ceritinib-cas-1032900-25-6-item-462148.html ...
By Alfa Chemistry based in NY, NEW YORK (USA).
-
TCB001 ImmuniCell Clinical Trial
This trial investigated the safety profile of large numbers of GDT cells derived from patients and was open to certain patients with skin, kidney or lung cancers. This trial is now closed. ...
By TC BioPharm based in Holytown, UNITED KINGDOM.
-
PTR-MS systems for medical applications
PTR-MS are powerful tools for non-invasive, real-time breath gas analysis with many applications, such as screening for disease markers, study of pharmacokinetics or metabolic ...
By Ionicon Analytik Ges.m.b.H. based in Innsbruck, AUSTRIA.
-
Predict Health Monitoring
Predict Health Monitoring provides online Occupational Health Screening Assessment Tools, giving insight into the health status of your work force at any one ...
By Enigma based in Auckland, NEW ZEALAND.
-
Flagship Coil for Smoking Addiction Treatment
BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) is a safe and effective aid for short-term smoking cessation in adults, representing the first FDA clearance in the addiction space for any TMS ...
By BrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA).
-
Targeted genetic sequencing solutions for pulmonary sector
Many genetic lung diseases have associated complications involving other organs that, if detected early, can be treated effectively. Early diagnosis is important for preserving lung function. Once a diagnosis of any type of rare lung disease is confirmed, patients will be closely monitored for the development of complications, including lung infection, pneumothorax (collapsed lung), or end-stage lung disease. Earlier diagnosis, leading to earlier initiation of preventative therapies, can improve long-term lung ...
By Tesis Biosciences based in Scottsdale, ARIZONA (USA).
-
Robotic-Assisted Bronchoscopy System for Lung Cancer Statistics
Lung cancer is the leading cause of cancer deaths worldwide. More Americans die each year from lung cancer than from prostate, breast and colon cancers ...
By Auris Health, Inc. based in Redwood City, CALIFORNIA (USA).
-
Robotic-Assisted Bronchoscopy System for Lung Nodules
The presence of a nodule in your lung, more commonly known as a mass or “spot” on your lungs, can be quite scary. However, a lung nodule or mass is a lot more common than you might think. Many nodules are benign, meaning that they are not cancer. It is important to know what type of lung nodule you have. ...
By Auris Health, Inc. based in Redwood City, CALIFORNIA (USA).
-
RNA Technology for Product Pipeline Research
Our product pipeline shows the progress we’re making on clinical programs currently in development to create mRNA medicines for a wide range of diseases and conditions. We are proud of the advancements we’ve made in pioneering new mRNA vaccines and treatments that may have the potential to treat and prevent rare ...
By Moderna, Inc. based in Cambridge, MASSACHUSETTS (USA).
-
Immunoscore for IC in Lung Cancer
IMMUNOSCORE® IC is intended for the detection of PD-L1 protein and the concomitant detection of CD8 + cells in Non-Small Cell Lung cancer (NSCLC) ...
By Veracyte based in Marseille Cedex 9, FRANCE.
-
Highly customized aptamer discovery solutions for hot areas for aptamers sector
Aptamers are short strands of DNA or RNA with unique secondary and tertiary structures that enable highly selective binding to various types of targets. While aptamers are similar to antibodies in their ability to specifically bind with high affinity, there are some key differences between antibodies and aptamers which have prompted an increase in aptamer development projects. Several hot areas for aptamers, along with specific aptamer advantages, are outlined below. ...
By Base Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA).
-
Diagnostic Solutions for Lung Cancer
Non-small cell lung cancer (NSCLC) is not a single disease, but a collection of cancer types whose pathology is classified by histology (cells) and molecular profiling (genetic and protein ...
By Biocept based in San Diego, CALIFORNIA (USA).
-
Quench - Aerosol Platform Technology for Lung Cancer
Despite the use of aggressive surgery and combination chemotherapy, lung cancer remains difficult to control and is the biggest killer among cancers at 154,000 annual US deaths. Lung cancer kills more people per year than prostate, pancreas, breast, and colon cancers combined. ...
By Quench Medical Inc. based in St Paul, MINNESOTA (USA).
-
IGX Platform Software for Immuno-Oncology
Monoclonal antibodies (mAbs) are used to treat patients in a variety of conditions such as infectious disease, cancer, and autoimmunity. Discovery of therapeutic antibodies is a laborious process, that depends on high-throughput screening of antibody candidates to determine antigen specificity. Immune repertoire analysis provides accurate, sensitive, and rapid detection of antibody sequences in panning rounds or exposured animal models, accelerating the discovery of ...
By Enpicom B.V. based in s-Hertogenbosch, NETHERLANDS.
-
Multi-Function Ventilator for Healthcare Professionals
Simply script for a “multi-function ventilator.” Patients must meet the medical necessity for ventilation and only one additional therapy (oxygen, cough, suction, or ...
By Ventec Life Systems based in Bothell, WASHINGTON (USA).
-
Clean air solutions for pollution area
SMOG: Smog is a type of air pollution and comes from the words smoke and fog, which refers to smoky fog. This air pollution consists of nitrogen oxides, sulfur oxides, ozone, smoke or dirt particles and even less visible particles. Smog arises from carbon, vehicle and industrial emissions as well as forest fires etc. Today we also know that air pollution can react in the atmosphere with sunlight and form new pollutants sk. photochemical smog. Smog is very toxic and can cause serious illness, shortened life or ...
By NoseOption AB based in Stockholm, SWEDEN.
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you